Oct 12, 2017 Cellectar Biosciences Announces Successful Completion of $7.76 Million Registered Direct Offering Learn More
Oct 10, 2017 Cellectar Biosciences Announces $7.76 Million Registered Direct Offering Priced At-The-Market Learn More
Oct 10, 2017 Cellectar Biosciences and Pierre Fabre Extend Collaboration for Development of New Phospholipid Drug Conjugates Learn More